Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy

Journal of Antimicrobial Chemotherapy

Volumn 47, Issue 2, 2001, Pages 129-140

  Dagan, Ron ^a,e   Klugman, Keith P ^b   Craig, William A ^c   Baquero, Fernando ^d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e NONE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN; CHLORAMPHENICOL; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; AREA UNDER THE CURVE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIUM CARRIER; CLINICAL TRIAL; CLONE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; ERADICATION THERAPY; EVIDENCE BASED MEDICINE; HAEMOPHILUS INFLUENZAE; HUMAN; LOBAR PNEUMONIA; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MORTALITY; NASOPHARYNX; OTITIS MEDIA; PRESCRIPTION; RESPIRATORY TRACT INFECTION; REVIEW; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

EID: 0035136786     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/47.2.129     Document Type: Review

References (53)

1. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
2. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis
3. Can the choice of antibiotics for therapy of acute otitis media be logical?
4. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters
5. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis
6. Antimicrobials for acute otitis media? A review from the international primary care network
7. Efficacy of fixed combination antibiotics versus separate components in otitis media. Effectiveness of erythromycin estrolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and acute otitis media under two and one-half years of age
8. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome
9. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The 'Pollyanna phenomenon'
10. Bacteriologic response to oral cephalosporins: Are established susceptibility breakpoints appropriate in the case of acute otitis media?
11. Bacteriologic and clinical efficacy of cefixime compared with amoxicillin in acute otitis media
12. Cefixime compared with amoxicillin for treatment of acute otitis media
13. Bacteriologic response in acute otitis media: Comparison between azithromycin, cefaclor and amoxicillin
14. Bacteriologic response to acute otitis media caused by Haemophilus influenzae treated with azithromycin
15. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children
16. Bacteriologic and clinical efficacy of amoxicillin/clavulanate versus azithromycin in acute otitis media
17. The pharmacokinetics of azithromycin in human serum and tissues
18. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
19. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin
20. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods
21. Pneumococcal macrolide resistance-myth or reality?
22. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics
23. The bacteriologic efficacy of 1-day versus 3-day intramuscular ceftriaxone (IMN-CRO) in the treatment of non-responsive acute otitis media (NR-AOM)
24. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci
25. Evolving resistance patterns of Streptococcus pneumoniae: A link with long-acting macrolide consumption?
26. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens-findings of the Alexander Project 1992-1996
27. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel
28. Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media
29. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study
30. Continued decline in the incidence of penicillin non-susceptible pneumococci in Iceland
31. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children
32. Erythromycin resistance of Streptococcus pyogenes in Madrid
33. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain
34. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
35. Low dosage and long treatment duration of beta-lactam: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae
36. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections
37. Antimicrobial resistance issues of the future
38. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
39. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models
40. Eradication of bacterial pathogens from middle ear infections
41. Microbiologic efficacy of antibacterial drugs for acute otitis media
42. Penicillin dosing for pneumococcal pneumonia
43. Antibiotic-resistant pneumococcal disease in South African children
44. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease
45. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children
46. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae
47. Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia
48. Effect of penicillin susceptibility on hospitalization length and mortality in Streptococcus pneumoniae infections
49. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention
50. Resistant and susceptible penicillin pneumococcal pneumonia-comparative study
51. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain